Our leadership team.

Mr. Woo Jin Lee is the Chief Executive Officer of GC Biopharma USA, Inc., bringing more than 26 years of experience in the global healthcare industry. He has held various senior executive management positions throughout his career. Currently, he serves as the Vice President of GC Biopharma (formerly known as Green Cross Corporation), one of the leading plasma protein product manufacturers globally. Under his leadership, GC Biopharma's overseas business grew substantially in Brazil, Russia, and the Middle East. Mr. Lee's success enabled him to establish key alliances with international organizations worldwide, such as the World Health Organization, UNICEF, and the Pan American Health Organization. Mr. Lee built and grew new operations for GC Biopharma in Sao Paulo, Brazil, and Vietnam establishing strategic business centers in both countries.

Mr. Lee has a proven track record within turn-key technology transfer, toll manufacturing, business development, and sales and marketing. He is a determined leader dedicated to delivering top-quality products and services which enhance the lives of people. Mr. Lee holds a Bachelor's degree in Genetic Engineering from SungKyunKwan University, South Korea.

Dr. Lisa Betts comes to GC Biopharma USA, Inc. with over 27 years of experience in immunoglobulin therapy. She previously served in senior and executive-level positions with responsibility for sales and operations in several large national healthcare companies. Throughout her career, Dr. Betts has successfully launched new drugs and built programs around them. As the founder and co-owner of Rx Solutions Inc., she created a specialty pharmacy company focused on the clinical management and outcomes of IG in specific chronic disease states. Rx Solutions Inc. grew exponentially and was purchased by Walgreens in 2009.

Since starting her career, she has focused on and been passionate about plasma-based products. Dr. Betts has spoken across the U.S. on plasma therapies and other health care topics and is the recipient of numerous professional honors. She attended the University of Illinois at Chicago – College of Pharmacy, where she received her Doctor of Pharmacy degree.

Dr. Alan Huber was educated as a clinical pharmacist with Bachelor's degrees in Pharmacy and Zoology from the University of Maryland, a Doctor of Pharmacy Degree from Shenandoah University and a Master of Business Administration from The George Washington University School of Business. After completing a two-year internship in IV therapy at the National Institutes of Health in Bethesda, Maryland, he has worked in the Specialty Pharmacy field for the past 20 years, serving in various positions throughout the industry including management roles in both nationally accredited home infusion companies and the plasma pharmaceutical industry.

Dr. Huber served as Adjunct Assistant Professor of Pharmacy Practice at the University of Southern California School of Pharmacy, where he lectured on immunoglobulin therapy. He has also been a preceptor for several pharmacy schools in the U.S. teaching immunoglobulin therapy. Over the years, Dr. Huber has presented widely on the topic of Ig therapy at many national conferences.

Ms. Mary Longarini comes to GC Biopharma USA, Inc with extensive experience in the pharmaceutical industry. She has more than 20 years in senior leadership positions within the plasma industry. Throughout her career she has led teams and found success with various product launches. Both her US plasma industry and commercial start-up experience have been instrumental in building the market access framework for GC Biopharma USA, Inc. Ms. Longarini has received many distinguished honors throughout her pharmaceutical career. She is a graduate of Penn State University and a commissioned officer in the United States Army.